Ian R. Mackay

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.

In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.

Journal: Cellular & molecular immunology
Published: January 11, 2018

Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis.

Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis.

Journal: Scientific reports
Published: November 27, 2015

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: October 01, 2015

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Journal: The American journal of gastroenterology
Published: September 30, 2015

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 21, 2015

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Journal: Hepatology (Baltimore, Md.)
Published: August 25, 2015

Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Journal: Gut
Published: August 20, 2015

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Journal: Journal of hepatology
Published: June 19, 2015

Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Journal: Gastroenterology
Published: June 19, 2015

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Journal: Clinics and research in hepatology and gastroenterology
Published: June 19, 2015

Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

Journal: Hepatology (Baltimore, Md.)
Published: November 23, 2014

Gut reactions--from celiac affection to autoimmune model.

Gut reactions--from celiac affection to autoimmune model.

Journal: The New England journal of medicine
Published: July 03, 2014
Showing 1-12 of 19

Last Updated: 09/26/2026